InBr3-Catalyzed Conjugate Addition of Indoles to p-Quinones: An Efficient Synthesis of 3-Indolylquinones

Synthesis

Volumn , Issue 1, 2004, Pages 106-110

  Yadav, J S ^a   Reddy, B V S ^a   Swamy, T ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Indium compounds; Indol 3 yl benzoquinones; Indoles; p quinones

Indexed keywords

ADDITION REACTIONS; CATALYST ACTIVITY; INDIUM COMPOUNDS; NITROGEN COMPOUNDS;

MICHAEL ADDITION;

SYNTHESIS (CHEMICAL);

2 (1H INDOL 3 YL) 1,4 NAPHTHOQUINONE; 2 (1H INDOL 3 YL) 5 METHYLBENZO 1,4 QUINONE; 2 (2 METHYL 1H INDOL 3 YL) 1,4 HYDROQUINONE; 2 (2 METHYL 1H INDOL 3 YL) 1,4 NAPHTHOQUINONE; 2 METHOXY 5 (2 METHYL 1H INDOL 3 YL)BENZO 1,4 QUINONE; 2 METHYL 3 (2 METHYL 1H INDOL 3 YL) 1,4 DIHYDRO 1,4 NAPHTHALENEDIONE; 2 METHYL 5 (2 METHYL 1H INDOL 3 YL)BENZO 1,4 QUINONE; 2,5 BIS(1H INDOL 3 YL) 1,4 HYDROQUINONE; 2,5 DICHLORO 3 (1 METHYL 1H INDOL 3 YL) 1,4 BENZENEDIOL; 2,5 DICHLORO 3 (1H INDOL 3 YL) 1,4 BENZENEDIOL; 2,5 DICHLORO 3 (2 METHYL 1H INDOL 3 YL) 1,4 BENZENEDIOL; 2,5 DICHLORO 3 (7 ETHYL 1H INDOL 3 YL) 1,4 BENZENEDIOL; 3 (5 BROMO 1H INDOL 3 YL) 2,5 DICHLORO 1,4 BENZENEDIOL; 3,5 DIMETHYL 2 (2 METHYL 1H INDOL 3 YL)BENZO 1,4 QUINONE; BENZOQUINONE DERIVATIVE; BROMINE DERIVATIVE; ETHYL 3 (2,5 DIHYDROXYPHENYL) 2 INDOLECARBOXYLATE; INDIUM BROMIDE; INDOLE DERIVATIVE; UNCLASSIFIED DRUG;

ADDITION REACTION; ARTICLE; CATALYSIS; CATALYST; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; MICHAEL ADDITION; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 0347949534     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44364     Document Type: Article

References (23)

1. (a) Arai, K.; Yamamoto, Y. Chem. Pharm. Bull 1990, 38, 2929.
2. (b) Kaji, A.; Saito, R.; Nomura, M.; Miyamoto, K.; Kiriyama, N. Biol. Pharm. Bull. 1998, 21, 945.
3. (a) Brewer, D.; Jerram, W.; Taylor, A. Can. J. Microbiol. 1968, 14, 861.
4. (b) Sekita, S. Chem. Pharm. Bull. 1983, 31, 2998.
5. (c) Kaji, A.; Saito, R.; Hata, Y.; Kiriyama, N. Chem. Pharm. Bull. 1999, 47, 77.
6. (a) Arai, K.; Shimizu, S.; Taguchi, Y.; Yamamoto, Y. Chem. Pharm. Bull. 1981, 29, 991.
7. (b) Shimizu, S.; Yamamoto, Y.; Koshimura, S. Chem. Pharm. Bull. 1982, 30, 1896.
8. (c) Kaji, A.; Iwata, T.; Kiriyama, N.; Wakusawa, S.; Miyamoto, K. Chem. Pharm. Bull. 1994, 42, 1682.
9. (a) Alvi, K. A.; Pu, H.; Luche, M.; Rice, A.; App, H.; McMahon, G.; Dare, H.; Margolis, B. J. Antibiot. 1999, 52, 215.
10. (b) Kaji, A.; Saito, R.; Nomura, M.; Miyamoto, K.; Kiriyama, N. Anticancer Res. 1997, 17, 3675.
11. Zhang, B.; Salituro, G.; Szalkowski, D.; Li, Z.; Zhang, Y.; Royo, I.; Vilella, D.; Diez, M. T.; Pelaez, F.; Ruby, C.; Kendall, R. L.; Mao, X.; Griffin, P.; Calaycay, J.; Zierath, J. R.; Heck, J. V.; Smith, R. G.; Moller. D. E. Science 1999, 284, 974.
12. (a) Mohlau, R.; Redlich, R. Ber. Dtsch. Chem. Ges. 1911, 44, 3605.
13. (b) Bu'Lock, J. D.; Harley-Mason, J. J. Chem. Soc. 1951, 703.
14. (c) Maiti, A. K.; Bhattacharya, P. J. Chem. Res., Synop. 1997, 424.
15. (a) Pirrung, M. C.; Park, K.; Li, Z. Org. Lett. 2001, 3, 365.
16. (b) Pirrung, M. C.; Deng, L.; Li, Z.; Park, K. J. Org. Chem. 2002, 67, 8374.
17. (a) Babu, G.; Perumal, P. T. Aldrichimica Acta 2000, 33, 16.
18. (b) Ghosh, R. Indian J. Chem., Sect. B 2001, 40, 550.
19. (a) Ceschi, M. A.; Felix, L. A.; Peppe, C. Tetrahedron Lett. 2000, 41, 9695.
20. (b) Bandini, M.; Cozzi, G. P.; Giocomini, M.; Melchiorre, P.; Selva, S.; Umani-Ronchi, A. J. Org. Chem. 2002, 67, 3700.
21. (c) Yadav, J. S.; Reddy, B. V. S. Synthesis 2002, 511.
22. (d) Yadav, J. S.; Reddy, B. V. S.; Raju, A. K.; Rao, C. V. Tetrahedron Lett. 2002, 43, 5437.
23. Harris, G. D. Jr.; Nguyen, A.; App, H.; Hirth, P.; McMahon, G.; Tang, C. Org. Lett. 1999, 1, 431.